Innate Pharma Sa Share Price (NASDAQ: IPHA)
$2.16
▲
0.07
(3.35%)
Last updated on
Check the interactive Innate Pharma Sa Stock chart to analyse performance
Innate Pharma Sa Key Stats
Check Innate Pharma Sa key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Innate Pharma Sa Stock including INR - Dollar returns
The Innate Pharma Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Innate Pharma Sa investment value today
Current value as on today
₹1,00,021
Returns
₹21
(+0.02%)
Returns from Innate Pharma Sa Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Innate Pharma Sa Stock
Global Institutional Holdings in Innate Pharma Sa
Name
Holdings %
Exchange Traded Concepts, LLC
0.07%
Morgan Stanley - Brokerage Accounts
0.05%
Citadel Advisors Llc
0.03%
Millennium Management LLC
0.02%
UBS Group AG
0.01%
Analyst Recommendation on Innate Pharma Sa Stock
Buy
70%Buy
30%Hold
0%Sell
Based on 10 Wall street analysts offering stock ratings for Innate Pharma Sa(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Innate Pharma Sa Share Price Target
What analysts predicted
Upside of 265.39%
Target:
$7.89
Current:
$2.16
Innate Pharma Sa share price target is $7.89, a slight Upside of 265.39% compared to current price of $2.16 as per analysts' prediction.
Innate Pharma Sa Stock Insights
Price Movement
In the last 7 days, IPHA stock has moved down by -7.1%Decreasing Revenue
Revenue is down for the last 3 quarters, 21.44M → 276.0K (in $), with an average decrease of 70.1% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -24.76M → -24.70M (in $), with an average increase of 0.2% per quarterIPHA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 78.8%IPHA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 138.0%Price to Sales
ForIPHA every $1 of sales, investors are willing to pay $8.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Innate Pharma Sa Financials
Innate Pharma Sa Technicals Summary
Sell
Neutral
Buy
Innate Pharma Sa is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Innate Pharma Sa Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -2.79% | 0.0% | -8.44% | -19.62% | -66.91% |
 | 3.92% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 2.49% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -15.42% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 11.08% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.78 | -1.63 | -0.23 | NA | 0.11 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $197.8M | -66.91% | NA | -245.87% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Innate Pharma Sa
Key Management of Innate Pharma Sa
Important FAQs about investing in IPHA Stock from India :
What is Innate Pharma Sa share price today?
Innate Pharma Sa share price today is $2.16 as on at the close of the market. Innate Pharma Sa share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Innate Pharma Sa share?
Innate Pharma Sa share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Innate Pharma Sa stock price today i.e. is closed at $2.16, lower by 38.47% versus the 52 week high.
How to invest in Innate Pharma Sa Stock (IPHA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Innate Pharma Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Innate Pharma Sa Shares that will get you 0.6944 shares as per Innate Pharma Sa share price of $2.16 per share as on August 30, 2025 at 1:28 am IST.
What is the minimum amount required to buy Innate Pharma Sa Stock (IPHA) from India?
Indian investors can start investing in Innate Pharma Sa (IPHA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Innate Pharma Sa stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Innate Pharma Sa share’s latest price of $2.16 as on August 30, 2025 at 1:28 am IST, you will get 4.6296 shares of Innate Pharma Sa. Learn more about
fractional shares .
What are the returns that Innate Pharma Sa has given to Indian investors in the last 5 years?
Innate Pharma Sa stock has given -66.91% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%